Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

SynBiotic SE (SBX.BE)

3.4050
+0.5700
+(20.11%)
As of 8:01:25 AM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,861.3560
3,861.3560
8,165.6260
8,648.5500
5,472.1810
Cost of Revenue
2,354.9380
2,354.9380
4,593.4920
3,863.1800
1,733.2470
Gross Profit
1,506.4180
1,506.4180
3,572.1340
4,785.3700
3,738.9340
Operating Expense
12,717.9990
12,717.9990
28,978.5470
16,636.3290
4,459.6420
Operating Income
-11,211.5810
-11,211.5810
-25,406.4130
-11,850.9590
-720.7080
Net Non Operating Interest Income Expense
-113.4880
-113.4880
-37.1060
86.9390
-2.6400
Pretax Income
-11,871.1830
-11,871.1830
-26,186.4380
-13,359.3210
-858.7980
Tax Provision
-134.9090
-134.9090
-188.8110
-289.7110
21.5910
Net Income Common Stockholders
-10,630.5970
-10,630.5970
-24,362.1720
-12,724.6100
-880.3890
Diluted NI Available to Com Stockholders
-10,630.5970
-10,630.5970
-24,362.1720
-12,724.6100
-880.3890
Basic EPS
-2.24
--
-5.97
-4.09
-0.55
Diluted EPS
-2.24
--
-5.97
-4.09
-0.55
Basic Average Shares
4,749.3160
--
4,081.7800
3,112.5080
1,584.8820
Diluted Average Shares
4,749.3160
--
4,081.7800
3,112.5080
1,584.8820
Total Expenses
15,072.9370
15,072.9370
33,572.0390
20,499.5090
6,192.8890
Net Income from Continuing & Discontinued Operation
-10,630.5970
-10,630.5970
-24,362.1720
-12,724.6100
-880.3890
Normalized Income
-9,889.6087
-9,889.6087
-23,342.1619
-12,608.8970
-801.1399
Interest Income
81.7490
81.7490
151.7920
133.5830
20.2330
Interest Expense
195.2370
195.2370
188.8980
46.6440
22.8730
Net Interest Income
-113.4880
-113.4880
-37.1060
86.9390
-2.6400
EBIT
-11,675.9460
-11,675.9460
-25,997.5400
-13,312.6770
-835.9250
EBITDA
-7,122.5990
-7,122.5990
-7,485.6550
-4,997.5090
-716.1210
Reconciled Cost of Revenue
2,354.9380
2,354.9380
4,593.4920
3,863.1800
1,733.2470
Reconciled Depreciation
4,553.3470
4,553.3470
18,511.8850
8,315.1680
119.8040
Net Income from Continuing Operation Net Minority Interest
-10,630.5970
-10,630.5970
-24,362.1720
-12,724.6100
-880.3890
Total Unusual Items Excluding Goodwill
-749.5060
-749.5060
-1,027.4180
-118.2780
-113.2130
Total Unusual Items
-749.5060
-749.5060
-1,027.4180
-118.2780
-113.2130
Normalized EBITDA
-6,373.0930
-6,373.0930
-6,458.2370
-4,879.2310
-602.9080
Tax Rate for Calcs
0
0
0
0
0.0003
Tax Effect of Unusual Items
-8.5177
-8.5177
-7.4079
-2.5650
-33.9639
12/31/2020 - 1/19/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EIIA.F Eisai Co Ltd
6.00
+0.84%
 
TEVA.VI Teva Pharmaceutical Industries Limited
13.70
+1.86%
 
H5P.F Hikma Pharmaceuticals PLC
23.20
0.00%
 
HIGH.DU Cantourage Group SE
4.8300
-1.63%
 
EVT.VI Evotec SE
7.29
-2.67%
 
PHE.F Cipher Pharmaceuticals Inc.
8.20
-2.38%
 
LDZU.F Aspen Pharmacare Holdings Limited
5.60
+2.75%
 
I7G.F Ipsen S.A.
99.40
+0.66%
 
EII.F Eisai Co., Ltd.
25.06
+0.93%
 
SGFEF Siegfried Holding AG
102.50
0.00%